Mar 2, 2026 07:03AM
Mar 2, 2026 07:00AM
Feb 26, 2026 06:40PM
Feb 26, 2026 05:55PM
Feb 17, 2026 07:30AM
Jan 8, 2026 07:00AM
Dec 1, 2025 07:01AM Xeris receives patent allowance for hypothyroidism drug candidate XP-8121
Dec 1, 2025 07:00AM
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Oct 23, 2025 07:30AM
Aug 7, 2025 07:03AM
Aug 7, 2025 07:00AM
Jul 31, 2025 07:30AM Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025
May 8, 2025 07:03AM
May 8, 2025 07:00AM
May 1, 2025 07:00AM
Mar 6, 2025 07:04AM
Mar 6, 2025 07:00AM
Feb 27, 2025 07:00AM
Jan 10, 2025 07:05AM Xeris Pharmaceuticals Inc. (XERS) Expects to Exceed Full-Year 2024 Financial Guidance
Jan 10, 2025 07:00AM
Nov 8, 2024 07:03AM
Nov 8, 2024 07:00AM
Oct 31, 2024 08:00AM
Aug 8, 2024 07:11AM
Aug 8, 2024 07:00AM
Jul 25, 2024 07:00AM Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
Jul 8, 2024 07:00AM
May 9, 2024 07:04AM
May 9, 2024 07:00AM
May 2, 2024 07:00AM
Mar 6, 2024 07:04AM
Mar 6, 2024 07:02AM
Feb 28, 2024 07:00AM Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
Jan 4, 2024 07:04AM
Jan 4, 2024 07:00AM
Nov 9, 2023 07:05AM
Nov 9, 2023 07:00AM
Oct 16, 2023 07:01AM
Oct 16, 2023 07:00AM
Aug 8, 2023 07:08AM Xeris Pharmaceuticals Inc. (XERS) Misses Q2 EPS by 2c, beats revenue
Aug 8, 2023 07:00AM
Aug 1, 2023 07:00AM
May 9, 2023 08:04AM
May 9, 2023 07:00AM
May 2, 2023 07:00AM
Mar 8, 2023 06:30AM
Mar 8, 2023 06:00AM Xeris Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
Feb 23, 2023 07:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All